{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:38:39Z","timestamp":1781897919440,"version":"3.54.5"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ibneur.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T12:32:58Z","timestamp":1646829178000},"page":"203-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["SUMO-modifying Huntington\u2019s disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Ericks S.","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Brocardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena I.","family":"Cimarosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2022.03.002_bib1","series-title":"Advances in Experimental Medicine","first-page":"261","article-title":"SUMOylation: implications for neurodegenerative diseases","author":"Anderson","year":"2017"},{"key":"10.1016\/j.ibneur.2022.03.002_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2022.03.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2021.689332","article-title":"Huntingtin and the synapse","volume":"15","author":"Barron","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib4","first-page":"2223","article-title":"Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington\u2019s disease therapy","volume":"44","author":"Carbo","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ibneur.2022.03.002_bib5","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/febs.15319","article-title":"Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts","volume":"287","author":"Celen","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.ibneur.2022.03.002_bib6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","article-title":"Sumo: from bench to bedside","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ibneur.2022.03.002_bib7","first-page":"1","article-title":"The function of SUMOylation and its crucial roles in the development of neurological diseases","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.ibneur.2022.03.002_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cbic.202000508","article-title":"Site-specific phosphorylation of huntingtin exon 1 recombinant proteins enabled by the discovery of novel kinases","volume":"22","author":"Chiki","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ibneur.2022.03.002_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41570-020-00223-8","article-title":"Deciphering protein post-translational modifications using chemical biology tools","volume":"4","author":"Conibear","year":"2020","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ibneur.2022.03.002_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2018.08.010","article-title":"A role for autophagy in Huntington\u2019s disease","volume":"122","author":"Croce","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2022.03.002_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/acel.12359","article-title":"The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration","volume":"14","author":"Deger","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.ibneur.2022.03.002_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbamcr.2007.03.017","article-title":"SUMO on the road to neurodegeneration","volume":"1773","author":"Dorval","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.ibneur.2022.03.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.603594","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease","volume":"11","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ibneur.2022.03.002_bib15","first-page":"70","article-title":"Gene targeting techniques for Huntington\u2019s disease","author":"Fields","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ibneur.2022.03.002_bib16","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00018-013-1530-y","article-title":"Cellular maintenance of nuclear protein homeostasis","volume":"71","author":"Gallagher","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib17","doi-asserted-by":"crossref","first-page":"32480","DOI":"10.1074\/jbc.M704314200","article-title":"A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis","volume":"282","author":"Gibb","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2022.03.002_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/jnc.13599","article-title":"SUMO-regulated mitochondrial function in Parkinson\u2019s disease","volume":"137","author":"Guerra De Souza","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.03.002_bib19","first-page":"1","article-title":"SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia","author":"Guo","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.ibneur.2022.03.002_bib20","first-page":"1","article-title":"Regulation of mitochondrial dynamics and neurodegenerative diseases","volume":"65","author":"Han","year":"2011","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.ibneur.2022.03.002_bib21","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.yexcr.2013.03.033","article-title":"The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes","volume":"319","author":"Harrison","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ibneur.2022.03.002_bib22","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10198-019-01092-9","article-title":"Health state utility values (QALY weights) for Huntington\u2019s disease: an analysis of data from the European Huntington\u2019s Disease Network (EHDN)","volume":"20","author":"Hawton","year":"2019","journal-title":"Eur. J. Heal. Econ."},{"key":"10.1016\/j.ibneur.2022.03.002_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2018.01.005","article-title":"Regulation of HSF1 protein stabilization: an updated review","volume":"822","author":"Huang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tibs.2020.09.002","article-title":"A chain of events: regulating target proteins by SUMO polymers","volume":"46","author":"Jansen","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib25","doi-asserted-by":"crossref","first-page":"13528","DOI":"10.1021\/bi0615644","article-title":"Human cystathionine \u03b2-synthase is a target for sumoylation","volume":"45","author":"Kabil","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ibneur.2022.03.002_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO signaling to wrestle cancer","volume":"7","author":"Kroonen","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ibneur.2022.03.002_bib27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aws022","article-title":"Supression of protein aggregation by chaperone modification of high molecular weight complexes","volume":"135","author":"Labbadia","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2022.03.002_bib28","first-page":"311","article-title":"Classification of extrapyramidal disorders","volume":"51","author":"Lakke","year":"1981","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib29","first-page":"1","article-title":"SUMO5, a novel poly-SUMO isoform, regulates PML nuclear bodies","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2022.03.002_bib30","first-page":"284","article-title":"Ubiquitin-dependent and independent roles of SUMO in proteostasis","volume":"311","author":"Liebelt","year":"2016","journal-title":"Am. J."},{"key":"10.1016\/j.ibneur.2022.03.002_bib31","doi-asserted-by":"crossref","first-page":"20265","DOI":"10.1073\/pnas.2002283117","article-title":"Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.03.002_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2131\/jts.42.529","article-title":"Increased SUMO-2\/3-ylation mediated by SENP3 degradation is protective against cadmium-induced caspase 3\u2013dependent cytotoxicity","volume":"42","author":"Luo","year":"2017","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.phrs.2017.12.023","article-title":"An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer\u2019s disease","volume":"130","author":"Marcelli","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ibneur.2022.03.002_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11064-015-1681-3","article-title":"Battling Alzheimer\u2019s disease: targeting SUMOylation-mediated pathways","volume":"41","author":"Martins","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2022.03.002_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mcn.2017.07.004","article-title":"Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington\u2019s disease pathways","volume":"83","author":"Moily","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2021836118","article-title":"PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington\u2019s disease","volume":"118","author":"Morozko","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.03.002_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuroscience.2018.05.027","article-title":"The thyroid hormone-target gene Rhes a novel crossroad for neurological and psychiatric disorders: new insights from animal models","volume":"384","author":"Napolitano","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.03.002_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation","volume":"4","author":"O\u2019Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ibneur.2022.03.002_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s disease-associated phenotypes in vivo","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2022.03.002_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2018.00379","article-title":"SUMO-targeted ubiquitin ligases (STUbLs) reduce the toxicity and abnormal transcriptional activity associated with a mutant, aggregation-prone fragment of huntingtin","volume":"9","author":"Ohkuni","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.ibneur.2022.03.002_bib42","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cellsig.2011.05.021","article-title":"The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery","volume":"23","author":"Palmer","year":"2011","journal-title":"Cell Signal."},{"key":"10.1016\/j.ibneur.2022.03.002_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci7060067","article-title":"Neuropsychiatric burden in Huntington\u2019s disease","volume":"7","author":"Paoli","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bandc.2011.07.009","article-title":"Biological markers of cognition in prodromal Huntington\u2019s disease: a review","volume":"77","author":"Papp","year":"2011","journal-title":"Brain Cogn."},{"key":"10.1016\/j.ibneur.2022.03.002_bib45","first-page":"24","article-title":"Protein aggregation and misfolding: good or evil?","author":"Pastore","year":"2012","journal-title":"J. Phys. Condens. Matter"},{"key":"10.1016\/j.ibneur.2022.03.002_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2003.07.004","article-title":"SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease","volume":"184","author":"Pountney","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000502142","article-title":"SUMOylation in neurodegenerative diseases","volume":"66","author":"Princz","year":"2020","journal-title":"Gerontology"},{"key":"10.1016\/j.ibneur.2022.03.002_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12038-020-00099-2","article-title":"Evaluation of post-translational modifications in histone proteins: a review on histone modification defects in developmental and neurological disorders","volume":"45","author":"Ramazi","year":"2020","journal-title":"J. Biosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/baab012","article-title":"Post-translational modifications in proteins: resources, tools and prediction methods","volume":"2021","author":"Ramazi","year":"2021","journal-title":"Database"},{"key":"10.1016\/j.ibneur.2022.03.002_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpns.47","article-title":"Overview of Huntington\u2019s disease models: neuropathological, molecular, and behavioral differences","volume":"83","author":"Rangel-Barajas","year":"2018","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ibneur.2022.03.002_bib52","first-page":"1","article-title":"Generation of native, untagged huntingtin exon1 monomer and fibrils using a SUMO fusion strategy","volume":"136","author":"Reif","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ibneur.2022.03.002_bib53","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/S1353-8020(09)70800-4","article-title":"Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics","volume":"15","author":"Ross","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2022.03.002_bib54","series-title":"International Review of Cell and Molecular Biology","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-386041-5.00004-2","article-title":"SUMO and its role in human diseases","author":"Sarge","year":"2011"},{"key":"10.1016\/j.ibneur.2022.03.002_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10040232","article-title":"Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review","volume":"10","author":"Schaffert","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/acschemneuro.9b00509","article-title":"SUMOylation prevents huntingtin fibrillization and localization onto lipid membranes","volume":"11","author":"Sedighi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22105326","article-title":"Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons\u2019 degeneration: link to Parkinson\u2019s disease","volume":"22","author":"Serra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib58","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1083\/jcb.201807068","article-title":"Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion","volume":"218","author":"Sharma","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-020-00689-0","article-title":"SUMO proteins in the cardiovascular system: friend or foe?","volume":"27","author":"Shetty","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019 s disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ibneur.2022.03.002_bib61","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4161\/cc.9.17.12718","article-title":"Does huntingtin play a role in selective macroautophagy?","volume":"9","author":"Steffan","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ibneur.2022.03.002_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of huntingtin and Huntington\u2019s disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2022.03.002_bib63","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1074\/jbc.C110.127191","article-title":"Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9","volume":"285","author":"Subramaniam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2022.03.002_bib64","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2022.03.002_bib65","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.neuropharm.2010.10.025","article-title":"Huntington\u2019s disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum)","volume":"60","author":"Subramaniam","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2022.03.002_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2015.05.011","article-title":"Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington\u2019s disease","volume":"82","author":"Swarnkar","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2022.03.002_bib67","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib68","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1097\/00001756-200212030-00038","article-title":"SUMO-1 co-localized with mutant atrophin-I with expanded polyglutamines accelerates intranuclear aggregation and cell death","volume":"13","author":"Terashima","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.ibneur.2022.03.002_bib69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: a quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib70","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0006-291X(02)00211-5","article-title":"Enhanced SUMOylation in polyglutamine diseases","volume":"293","author":"Ueda","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ibneur.2022.03.002_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2020.577380","article-title":"Inflammation in Huntington\u2019s disease: a few new twists on an old tale","volume":"348","author":"Valad\u00e3o","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib74","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ana.25007","article-title":"Body weight is a robust predictor of clinical progression in Huntington disease","volume":"82","author":"van der Burg","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2022.03.002_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/BST20190357","article-title":"Molecular mechanisms in SUMO conjugation","volume":"48","author":"Varej\u00e3o","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ibneur.2022.03.002_bib76","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1242\/jcs.050542","article-title":"SUMOylation and deSUMOylation at a glance","volume":"122","author":"Wang","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ibneur.2022.03.002_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12264-010-1118-6","article-title":"The role of post-translational modifications of huntingtin in the pathogenesis of Huntington\u2019s disease","volume":"26","author":"Wang","year":"2010","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ibneur.2022.03.002_bib78","series-title":"SUMO Regulation of Cellular Processes","first-page":"1","article-title":"Introduction to sumoylation","author":"Wilson","year":"2017"},{"key":"10.1016\/j.ibneur.2022.03.002_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-012-9358-z","article-title":"SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases","volume":"23","author":"Wong","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ibneur.2022.03.002_bib80","first-page":"1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","author":"Zou","year":"2020","journal-title":"Cell Biosci."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242122000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242122000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:09:32Z","timestamp":1757405372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242122000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":80,"alternative-id":["S2667242122000148"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2022.03.002","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SUMO-modifying Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}